SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (10057)5/1/2007 12:03:18 AM
From: Robohogs  Read Replies (1) of 10280
 
This is a pure guess - but I would assume flat to Xop nebulizer since basically similar users (although more elderly for Brovana and kids for Xopenex). One of the street analysts had 10% premium to Xopenex - might make some sense with NO neb competition. The average Xopenex scrip is something between $100-150 - hard to measure with the extreme seasonality. I would use $150 for now - I back of the head used $100 earlier and got an annual runrate of just over a million, probably $1.2 MM given IMS sampling error.

Jon
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News